Navigation Links
On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigan's Drug Product Liability Law

DETROIT, March 4 /PRNewswire/ -- On March 4, 2009, the United States Supreme Court in the case of Wyeth v. Levine, rejected the drug company's argument that because it was complying with FDA standards it should be immune from suit. Because of this decision, citizens in all states except Michigan can continue to sue drug companies whose products injure the citizens of those states.

During the term of former Governor John Engler, the Republican legislature passed a statute granting immunity to companies (drug companies) whose products are approved by the FDA. That statute which denied Michigan citizens the right to sue for injuries sustained from dangerous drugs was believed by drug companies to set a pattern which would allow the drug companies to deny the citizens in the other 49 states the right to sue.

Using the theory of "Federal Pre-emption" Wyeth told the United States Supreme Court that under the law it could not change its labeling to warn people such as Mrs. Levine that the Wyeth drug Phenergan by the iv - push method had the potential of causing serious injuries and death, including amputation, because the FDA laws did not allow such a change in the warnings. The United States Supreme Court found this to be untrue after analyzing the existing laws.

Two editorials in the leading medical journals, Journal of the American Medical Association and the New England Journal of Medicine, both criticized the attempts of the drug companies to seek immunity and encouraged the United States Supreme Court not to recognize Federal Pre-emption if it meant preventing state court actions against drug companies. The authors of these editorials pointed to the numerous drug products where drug companies hid information about the dangers of drugs that was only uncovered and made available to the medical profession by the filing of state lawsuits which allowed state courts to order drug companies to turn over documents that the drug companies had either hidden from the FDA or mischaracterized to the FDA.

The decision according to Michigan Trial Lawyer, J. Douglas Peters of Charfoos & Christensen, P.C., "This decision may have a sobering impact on the Republicans in the Michigan Senate which should immediately consider reversing Michigan's unique and unfair law to bring Michigan back into line with the law of the other 49 states, as recognized by the United States Supreme Court in its new decision."

According to Peters, "The drug industry had a special friend in Governor Engler, and Governor Engler tried to export his success for the drug companies in Michigan to the national level where he currently works as a lobbyist for various manufacturing interests."

Peters also stated that he " ... hopes the Michigan legislature will act quickly to change Michigan's consumer hostile drug law in light of this new United States Supreme Court decision, to protect the health, safety and welfare of Michigan citizens."

    For more information contact:
    J. Douglas Peters, Esq.
    Charfoos & Christensen, P.C.
    5510 Woodward Avenue
    Detroit, Michigan  48202
    (313) 875-8080

SOURCE Charfoos & Christensen, P.C.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. National Multiple Sclerosis(MS) Awareness Week is March 15-21
2. AMERIGROUP Corporation to Present at the Barclays Capital Global Healthcare Conference on March 10
3. Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day
4. Cardiogenesis Corporation to Report 2008 Fourth Quarter and Year-End Results on March 31st
5. Air Methods to Report Fourth Quarter and Fiscal Year 2008 Financial Results on Tuesday, March 10, 2009
6. PLC Systems to Host Fourth Quarter Conference Call on March 12, 2009
7. Osteotech Announces Fourth Quarter and Full Year 2008 Earnings Release and Conference Call; Company to Release Financial Results on Wednesday, March 4, 2009 and Host Call on Thursday, March 5, 2009
8. China Nepstar Chain Drugstore to Announce Fourth Quarter and Fiscal 2008 Financial Results on March 16
9. EyeCare America Offers No-Cost Medical Eye Care to Qualified Seniors In Support of National AMD Month - March 2009
10. March Is National Kidney Month
11. Triple-S Management Corporation to Host Inaugural Investor Day on March 5, 2009
Post Your Comments:
(Date:11/26/2015)... , ... November 26, 2015 , ... ... set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer ... classically-influenced trailer titles work with any font, giving users limitless opportunities to stylize ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the world-class ... improve system efficiency and reliability. , The new Q-Suite 6 platform is based on ... avoids locking itself into a specific piece of software for many key components of ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Water For Empowerment ™ attracts volunteers together who want to combine talents ... women as key stakeholders in the process. The non-profit launched its first major ...
(Date:11/25/2015)... MN (PRWEB) , ... November 25, 2015 , ... Finnleo, ... through Christmas Eve on several models of traditional and far-infrared saunas. , ... Nordic Spruce is the most traditional Finnish sauna wood, and Finnleo uses only European ...
(Date:11/25/2015)... ... November 25, 2015 , ... TyloHelo Inc , ... accessories. , Sauna accessories help improve the bather experience in the sauna, and ... styles for the purist looking for simplicity in design to accessories that encourage ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... AAIPharma Services Corp./Cambridge Major Laboratories, Inc. ... $15.8  Million to expand its laboratories and global ... The expansion will provide additional office space and ... of the pharmaceutical and biotechnology markets. ... up to 40,000 square feet of expanded development ...
(Date:11/25/2015)... MINNEAPOLIS , Nov. 25, 2015  ARKRAY ... care products, continues to provide evidence demonstrating the accuracy ... the World Congress on Insulin Resistance, Diabetes and Cardiovascular ... showed that both the Company,s GLUCOCARD ® 01 ... met high accuracy requirements. The ability to accurately measure ...
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
Breaking Medicine Technology: